Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/06/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2451 publications

Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid Leukemia.

Condition: Acute Myeloid Leukemia (AML)
Journal: Hematology/oncology and stem cell therapy
Treatment Used: Chimeric Antigen Receptor (CAR) T-Cell Therapy
Published: December 20, 2022

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

Condition: Adults with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
Journal: Journal of hematology & oncology
Treatment Used: KTE-X19
Number of Patients: 55
Published: December 09, 2022

Clinical Analysis of Salvage Treatment of Glucocorticoid Resistant Graft-Versus-Host Disease with Vedolizumab in Children.

Condition: Glucocorticoid Resistant Graft-Versus-Host Disease (GR-GVHD) in Children
Journal: Zhongguo shi yan xue ye xue za zhi
Treatment Used: Vedolizumab (VDZ)
Number of Patients: 5
Published: December 08, 2022

SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.

Condition: Acute Myeloid Leukemia (AML)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Maintenance Therapy
Published: December 01, 2022

An experience with ibrutinib monotherapy for Richter's syndrome isolated in the central nervous system.

Condition: Richeter's Syndrome (RS)
Journal: Journal of clinical and experimental hematopathology : JCEH
Treatment Used: Ibrutinib
Number of Patients: 1
Published: November 27, 2022

Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia.

Condition: Chronic Lymphocytic Leukemia
Journal: Cells
Treatment Used: Proteasome and mTORC1 Inhibitors
Published: November 26, 2022

An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial).

Condition: Acute Promyelocytic Leukemia (APL)
Journal: Blood cancer journal
Treatment Used: All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) vs. All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) Plus Chemotherapy (CHT)
Number of Patients: 128
Published: November 20, 2022

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.

Condition: High-Risk Classic Hodgkin Lymphoma
Journal: The Lancet. Haematology
Treatment Used: Brentuximab Vedotin Plus Nivolumab
Number of Patients: 59
Published: November 20, 2022

Impact of posttransplant cyclophosphamide on the outcome of patients undergoing unrelated single-unit umbilical cord blood transplantation for pediatric acute leukemia.

Condition: Pediatric Acute Leukemia
Journal: BMC cancer
Treatment Used: Posttransplant Cyclophosphamide (PTCY)
Number of Patients: 52
Published: November 19, 2022

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.

Condition: Philadelphia Chromosome-Positive (Ph-positive) Acute Lymphoblastic Leukemia
Journal: The Lancet. Haematology
Treatment Used: Ponatinib and Blinatumomab
Number of Patients: 72
Published: November 19, 2022

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.

Condition: Previously Treated B-Cell Malignancies
Journal: The Lancet. Haematology
Treatment Used: Zanubrutinib
Number of Patients: 67
Published: November 18, 2022

Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.

Condition: Relapsed/Refractory Multiple Myeloma (RRMM)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Ciltacabtagene Autoleucel
Number of Patients: 36
Published: November 10, 2022
Showing 1-12 of 2,451

Last Updated: 01/06/2023